Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
HealthStream
HSTM
HealthStream
Extended Sales Cycles Will Impede Revenue But Digital Trends Persist
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
22 Jun 25
Updated
23 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$29.00
10.6% undervalued
intrinsic discount
23 Jul
US$25.94
Loading
1Y
-7.5%
7D
-0.8%
Author's Valuation
US$29.0
10.6% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$29.0
10.6% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
336m
2014
2017
2020
2023
2025
2026
2028
Revenue US$335.9m
Earnings US$22.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.21%
Healthtech revenue growth rate
4.19%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.82%
Calculation
US$22.19m
Earnings '28
x
48.66x
PE Ratio '28
=
US$1.08b
Market Cap '28
US$1.08b
Market Cap '28
/
30.88m
No. shares '28
=
US$34.96
Share Price '28
US$34.96
Share Price '28
Discounted to 2025 @ 7.46% p.a.
=
US$28.17
Fair Value '25
